MPG.eBooks - Search Results

1

Pharmacoeconomic review report: Guselkumab (Tremfya) (Janssen Inc.)

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal / therapeutic use...”

Read Now

2

Pharmacoeconomic review report: Dupilumab (Dupixent) (Sanofi-Aventis Canada Inc.)

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal / therapeutic use...”

Read Now

3

Pharmacoeconomic review report: Lanadelumab (Takhzyro) (Shire pharma Canada ULC) : indication : for the routine prevention of attacks of hereditary angioedema in adolescents and ad...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antibodies, Monoclonal / therapeutic use...”

Read Now

4

Pharmacoeconomic review report: Dupilumab (Dupixent) (Sanofi-Aventis Canada Inc.)

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal / therapeutic use...”

Read Now

5

CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal / therapeutic use...”

Read Now

6

Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)

Published 2017

CADTH

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

7

Pharmacoeconomic review report: Sarilumab (Kevzara)

Published 2017

CADTH

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

8

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis

Published 2020

CADTH

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

9

CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis

Published 2020

CADTH

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

10

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

11

Pharmacoeconomic review report: Risankizumab (Skyrizi) (AbbVie)

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antibodies, Monoclonal / therapeutic use...”

Read Now

12

Pharmacoeconomic review report: Ixekizumab (Taltz)

Published 2017

CADTH

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

13

Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

14

Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

15

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

16

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

17

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal / therapeutic use...”

Read Now

18

CADTH Canadian Drug Expert Committee recommendation: Guselkumab (Tremfya -- Janssen Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasi...

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal / therapeutic use...”

Read Now

19

CADTH Canadian drug expert committee recommendation: Benralizumab (Fasenra -- Astrazeneca Canada Inc.) : indication : severe eosinophilic asthma

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal / therapeutic use...”

Read Now

20

Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Narrow Search